Literature DB >> 25061075

Educating the security forces, a high risk group in malaria elimination efforts: an example from Sri Lanka.

Sumadhya Deepika Fernando1, Chaturaka Rodrigo2, Nipun de Silva2, Saveen Semege3, Senaka Rajapakse2, Nilakashi Samaranayake4, Sanath Senenayake4, Risintha Gayan Premaratne5.   

Abstract

BACKGROUND: The security forces are a high risk group for malaria transmission in Sri Lanka. Interrupting transmission and maintaining surveillance in this group is an important component of elimination efforts. The objective of the study was to develop a prototype educational programme on malaria for security forces serving in endemic areas.
METHODS: An interactive seminar was designed to deliver the required knowledge. The content was on current status, transmission, signs and symptoms and the role of security personnel in identification and prevention of malaria. Each seminar was preceded by a pre-test and followed by a post test to assess the improvement of knowledge.
RESULTS: Fifty seminars were held in eight districts over 2 months with 2301 security forces personnel participating. Pre seminar knowledge on malaria was significantly better in the medical corps, those who had completed secondary education and in the Army compared to other security forces (p<0.001). Participation in the seminar resulted in an improvement in all domains tested as shown by test scores in post seminar assessment (p<0.001).
CONCLUSIONS: Conducting a formal educational programme is an effective strategy to improve awareness on malaria amongst security forces personnel who are a high risk group for re-introduction of malaria into the country.
© The Author 2014. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Educational programme; Elimination; Malaria; Prevention; Security Forces; Sri Lanka

Mesh:

Year:  2014        PMID: 25061075     DOI: 10.1093/inthealth/ihu044

Source DB:  PubMed          Journal:  Int Health        ISSN: 1876-3405            Impact factor:   2.473


  6 in total

Review 1.  Prospects for malaria elimination in Mesoamerica and Hispaniola.

Authors:  Sócrates Herrera; Sergio Andrés Ochoa-Orozco; Iveth J González; Lucrecia Peinado; Martha L Quiñones; Myriam Arévalo-Herrera
Journal:  PLoS Negl Trop Dis       Date:  2015-05-14

2.  Response of imported malaria patients to antimalarial medicines in Sri Lanka following malaria elimination.

Authors:  Priyani Dharmawardena; Chaturaka Rodrigo; Kamini Mendis; W M Kumudu T de A W Gunasekera; Risintha Premaratne; Pascal Ringwald; Deepika Fernando
Journal:  PLoS One       Date:  2017-11-28       Impact factor: 3.240

3.  Use of a public-private partnership in malaria elimination efforts in Sri Lanka; a case study.

Authors:  Deepika Fernando; Pandu Wijeyaratne; Rajitha Wickremasinghe; Rabindra R Abeyasinghe; Gawrie N L Galappaththy; Renu Wickremasinghe; M Hapugoda; W A Abeywickrema; Chaturaka Rodrigo
Journal:  BMC Health Serv Res       Date:  2018-03-23       Impact factor: 2.655

4.  The need for preventive and curative services for malaria when the military is deployed in endemic overseas territories: a case study and lessons learned.

Authors:  Sumadhya Deepika Fernando; Rahuman Booso; Priyani Dharmawardena; Arunagirinathan Harintheran; Kugapiriyan Raviraj; Chaturaka Rodrigo; Manjula Danansuriya; Rajitha Wickremasinghe
Journal:  Mil Med Res       Date:  2017-06-06

5.  What India can learn from globally successful malaria elimination programmes.

Authors:  Sachin Sharma; Reena Verma; Bhawna Yadav; Amit Kumar; Manju Rahi; Amit Sharma
Journal:  BMJ Glob Health       Date:  2022-06

6.  The risk of imported malaria in security forces personnel returning from overseas missions in the context of prevention of re-introduction of malaria to Sri Lanka.

Authors:  Sumadhya Deepika Fernando; Priyani Dharmawardana; Saveen Semege; Geetha Epasinghe; Niroshana Senanayake; Chaturaka Rodrigo; Risintha Premaratne
Journal:  Malar J       Date:  2016-03-08       Impact factor: 2.979

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.